From The Editor
-
FDA Leading The Decline Of Animal Testing
7/16/2025
The gold standard practice of conducting animal studies for evaluating toxicity, pharmacodynamics, and immunogenicity is being challenged by innovative alternatives – New Approach Methods (NAMs).
-
Governor Josh Shapiro On Supporting Biomanufacturing In Pennsylvania
7/15/2025
Bioprocess Online's coverage of Governor Josh Shapiro’s fireside chat with BIO CEO, John Crowley, at the 2025 BIO International Convention.
-
How CGT Leaders Are Reducing Failures, Scaling Processes, And Overcoming Regulatory Friction
6/30/2025
Industry leaders share their philosophy on reducing product failure, embracing AI, and building dynamic teams to stay ahead of the curve to bring curative CGT therapies to patients.
-
Finding Compatibility In Love And CDMO Partnerships
6/26/2025
Just like people, some sponsor-CDMO partnerships can be matches made in heaven. Others, not so much. See what experts have to say about finding the right CDMO and building a successful partnership together.
-
Five Takeaways from BIO 2025 and Why You Should Stay Tuned
6/26/2025
New chief editor of Drug Discovery Online shares insights from BIO 2025’s global biotech gathering and spotlights the impacts to early-stage drug research.
-
Lonza Bets On Biologics. What's It Mean For You?
6/26/2025
It’s a large and universally recognizable CDMO, so this matters. Swiss-based powerhouse Lonza will increase its focus on biologics, and “advanced synthesis” including for antibody-drug conjugates (ADCs), cell and gene therapies (CGT), and mRNA therapeutics. Will other CDMOs follow suit? What's this say about the future of development outsourcing and our industry?
-
BIO2025 Recap: FDA Reducing Animal Testing, Governor Shapiro On Supporting Biopharma, Practical AI Use
6/24/2025
Bioprocess Online chief editor Tyler Menichiello shares his three key takeaways from the 2025 BIO International Convention.
-
Analytics And Cross-Functional Communication: Keys To Purifying Complex Molecules
5/30/2025
This summary features key takeaways from the Bioprocess Online Live event, "Challenges And Considerations For Purifying Multispecific Molecules."
-
How Modular Facility Design Can Accelerate GMP Facility Construction
5/20/2025
Autolus Therapeutics' COO talks about the accelerated construction of the company's cell therapy manufacturing facility, The Nucleus.
-
A Facilities Expert Answers Audience Questions On Construction And Validation
5/5/2025
Bioprocessing facility expert Herman Bozenhardt responds to some unanswered audience questions from a Pharmaceutical Online Live event on facility design and validation.